Tycho Peterson Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 week, 2 days ago
Tycho Peterson has an estimated net worth of at least $11.1 million*, as of Oct. 29, 2025. They own 531,553 shares of ADPT stock. They have sold 258,417 shares of ADPT stock since 2021, for an estimated $2.0 million.
Tycho Peterson $ADPT SEC Form 4 Insider Trading
Tycho Peterson has filed a total of 6 insider trades in $ADPT since 2021. Their most recent trade was a sale of 15,456 shares, made on Mar 05, 2024. Their largest trade was a sale of 70,000 shares, made on Jun 20, 2023. We estimate that they now own 531,553 shares of $ADPT, worth an estimated $9.1 million.
Insider Trading at $ADPT
There have been a total of 163 insider trades reported at $ADPT since 2021, with 0 shares purchased and 2.4 million shares sold. The most active insider traders in $ADPT stock have been Harlan S Robins, Chad M Robins, and R Mark Adams. The most recent trade was a sale of 1,929 shares reported by KYLE PISKEL (Chief Financial Officer), made on May 16, 2025.
History of Insider Stock Trades by Tycho Peterson
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ADPT
|
Sale | 15,456 | Mar 05, 2024 | March 6, 2024, 8:40 p.m. |
ADPT
|
Sale | 70,000 | Jun 20, 2023 | June 21, 2023, 5:32 p.m. |
ADPT
|
Sale | 64,961 | Jun 20, 2023 | June 21, 2023, 5:32 p.m. |
ADPT
|
Sale | 55,672 | Jun 15, 2023 | June 20, 2023, 5:41 p.m. |
ADPT
|
Sale | 14,328 | Jun 15, 2023 | June 20, 2023, 5:41 p.m. |
ADPT
|
Sale | 38,000 | Jun 02, 2023 | June 6, 2023, 4:23 p.m. |
$ADPT Executives and Stock Owners with Insider Trades
-
Harlan S Robins, Chief Scientific Officer
-
Chad M Robins, CEO and Chairman
-
R Mark Adams, Chief Operating Officer
-
Chad M Cohen, Chief Financial Officer
-
Stacy L Taylor, SVP and General Counsel
-
Francis Lo, Chief People Officer
-
Nitin Sood, Chief Commercial Officer, MRD
-
Kyle Piskel, Principal Accounting Officer
-
Tycho Peterson, Chief Financial Officer
-
Kyle Piskel, Chief Financial Officer
-
Sharon Benzeno, Chief Commercial Ofc Imm Med
-
Julie Rubinstein, President
-
Jyoti Palaniappan, SVP, Diagnostics, T-Detect
-
Susan Bobulsky, Chief Commercial Officer, MRD
-
Lance Baldo, Chief Medical Officer
-
Julie Rubinstein, President and COO
-
Sharon Benzeno, Chief Business Development Off
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.